UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 122

Sortiert nach

Von Willebrand factor–cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura

Blood, 2002-07, Vol.100 (2), p.710-713

2002

Volltextzugriff (PDF)

Partial amino acid sequence of purified von Willebrand factor–cleaving protease

Blood, 2001-09, Vol.98 (6), p.1654-1661

2001

Volltextzugriff (PDF)

von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome

The New England journal of medicine, 1998-11, Vol.339 (22), p.1578-1584

1998

Volltextzugriff (PDF)

Cloning, expression, and functional characterization of the von Willebrand factor–cleaving protease (ADAMTS13)

Blood, 2002-11, Vol.100 (10), p.3626-3632

2002

Volltextzugriff (PDF)

Why the long-term charge offset drift in Si single-electron tunneling transistors is much smaller (better) than in metal-based ones:Two-level fluctuator stability

Journal of applied physics, 2008-08, Vol.104 (3), p.033710-033710-12

2008

Volltextzugriff (PDF)

Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura

Blood, 1997-05, Vol.89 (9), p.3097-3103

1997

Volltextzugriff (PDF)

Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP)

Thrombosis and haemostasis, 1999-11, Vol.82 (5), p.1386

1999

Volltextzugriff (PDF)

Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura

Thrombosis and haemostasis, 1999-01, Vol.81 (1), p.8

1999

Volltextzugriff (PDF)

Familial acquired thrombotic thrombocytopenic purpura: ADAMTS13 inhibitory autoantibodies in identical twins

Blood, 2004-06, Vol.103 (11), p.4195-4197

2004

Volltextzugriff (PDF)

Implications of the ICRU 95 quantities for various personal dosimetry techniques

Radiation measurements, 2024-08, Vol.176, p.107207, Article 107207

2024

Volltextzugriff (PDF)

Efficiency evaluation of leaded glasses and visors for eye lens dose reduction during fluoroscopy guided interventional procedures

Physica medica, 2022-08, Vol.100, p.129-134

2022

Volltextzugriff (PDF)

von Willebrand factor-cleaving protease in childhood diarrhoea-associated haemolytic uraemic syndrome

Thrombosis and haemostasis, 2001-06, Vol.85 (6), p.975

2001

Volltextzugriff (PDF)

von Willebrand factor in thrombotic thrombocytopenic purpura

Thrombosis and haemostasis, 1999-08, Vol.82 (2), p.592

1999

Volltextzugriff (PDF)

Cryogenic small-signal conversion with relaxation oscillationsin Josephson junctions

Journal of applied physics, 2006-08, Vol.100 (3), p.034511-034511-9

Furlan, Miha

2006

Volltextzugriff (PDF)

Cryogenic small-signal conversion with relaxation oscillations in Josephson junctions

Journal of applied physics, 2006-08, Vol.100 (3)

Furlan, Miha

2006

Volltextzugriff (PDF)

Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V

British journal of haematology, 1993-11, Vol.85 (3), p.528-532

1993

Volltextzugriff (PDF)

Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease

Best practice & research. Clinical haematology, 2001-06, Vol.14 (2), p.437-454

2001

Volltextzugriff (PDF)

Thrombotic thrombocytopenic purpura: a paradigm shift?

Thrombosis and haemostasis, 2000-10, Vol.84 (4), p.528

2000

Volltextzugriff (PDF)

Partial Purification and Characterization of a Protease From Human Plasma Cleaving von Willebrand Factor to Fragments Produced by In Vivo Proteolysis

Blood, 1996-05, Vol.87 (10), p.4223-4234

1996

Volltextzugriff (PDF)

Acquired Deficiency of von Willebrand Factor-Cleaving Protease in a Patient With Thrombotic Thrombocytopenic Purpura

Blood, 1998-04, Vol.91 (8), p.2839-2846

1998

Volltextzugriff (PDF)

Thromboembolism and bleeding tendency in congenital factor XII deficiency--a study on 74 subjects from 14 Swiss families

Thrombosis and haemostasis, 1991, Vol.65 (2), p.117

1991

Volltextzugriff (PDF)

Proteolytic cleavage of von Willebrand factor by ADAMTS‐13 prevents uninvited clumping of blood platelets

Journal of thrombosis and haemostasis, 2004-09, Vol.2 (9), p.1505-1509

Furlan, M.

2004

Volltextzugriff (PDF)

Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura

Expert review of cardiovascular therapy, 2003-08, Vol.1 (2), p.243-255

Furlan, Miha

2003

Volltextzugriff (PDF)

Imaging of single infrared, optical, and ultraviolet photons using distributed tunnel junction readout on superconducting absorbers

Journal of applied physics, 2007-03, Vol.101 (5), p.054501-054501-6

2007

Volltextzugriff (PDF)

Recombinant vWF type 2A mutants R834Q and R834W show a defect in mediating platelet adhesion to collagen, independent of enhanced sensitivity to a plasma protease

Thrombosis and haemostasis, 1999-06, Vol.81 (6), p.976

1999

Volltextzugriff (PDF)

1 – 25 von 122

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(93)

Publikationsform

Artikel
(118)
Buchkapitel
(4)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(79)
Humans
(65)
Life Sciences & Biomedicine
(64)
Hematology
(47)
Biological And Medical Sciences
(39)
Medical Sciences
(30)
Cardiovascular System & Cardiology
(25)
Peripheral Vascular Disease
(25)
Adam Proteins
(22)
Adamts13 Protein
(22)
Female
(22)
Adult
(20)
Hematologic And Hematopoietic Diseases
(20)
Platelet Diseases And Coagulopathies
(18)
Male
(16)
Metalloendopeptidases - Deficiency
(14)
Von Willebrand Factor - Metabolism
(13)
Middle Aged
(12)
Physical Sciences
(10)
Technology
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Von Willebrand factor–cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura

Partial amino acid sequence of purified von Willebrand factor–cleaving protease

von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome

Cloning, expression, and functional characterization of the von Willebrand factor–cleaving protease (ADAMTS13)

Why the long-term charge offset drift in Si single-electron tunneling transistors is much smaller (better) than in metal-based ones:Two-level fluctuator stability

Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura

Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP)

Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura

Familial acquired thrombotic thrombocytopenic purpura: ADAMTS13 inhibitory autoantibodies in identical twins

Implications of the ICRU 95 quantities for various personal dosimetry techniques

Efficiency evaluation of leaded glasses and visors for eye lens dose reduction during fluoroscopy guided interventional procedures

von Willebrand factor-cleaving protease in childhood diarrhoea-associated haemolytic uraemic syndrome

von Willebrand factor in thrombotic thrombocytopenic purpura

Cryogenic small-signal conversion with relaxation oscillationsin Josephson junctions

Cryogenic small-signal conversion with relaxation oscillations in Josephson junctions

Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V

Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease

Thrombotic thrombocytopenic purpura: a paradigm shift?

Partial Purification and Characterization of a Protease From Human Plasma Cleaving von Willebrand Factor to Fragments Produced by In Vivo Proteolysis

Acquired Deficiency of von Willebrand Factor-Cleaving Protease in a Patient With Thrombotic Thrombocytopenic Purpura

Thromboembolism and bleeding tendency in congenital factor XII deficiency--a study on 74 subjects from 14 Swiss families

Proteolytic cleavage of von Willebrand factor by ADAMTS‐13 prevents uninvited clumping of blood platelets

Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura

Imaging of single infrared, optical, and ultraviolet photons using distributed tunnel junction readout on superconducting absorbers

Recombinant vWF type 2A mutants R834Q and R834W show a defect in mediating platelet adhesion to collagen, independent of enhanced sensitivity to a plasma protease

Suchergebnisse filtern